Colon Cancer News and Research

Latest Colon Cancer News and Research

Lab-on-a-chip nanoscale array monitors cellular processes

Researchers at Tel-Aviv University in Israel have developed a lab-on-a-chip device that can incorporate enzymes and even living cells in a nanoscale array capable of monitoring electrochemical reactions.

30 Oct 2006

Confusion abounds on how to treat the menopause

The results in 2002 of a large U.S. study on hormone replacement therapy (HRT) in many respects left women confused and alarmed about the treatment for the menopause.

25 Oct 2006

ODC genetic variation impacts aspirin's effectiveness in preventing colon cancer

Dartmouth researchers are among a team of doctors that have learned more about how people may or may not benefit from taking aspirin in the effort to curb colon cancer.

24 Oct 2006

National Eye Institute to finance two-year study comparing effectiveness of treatments for macular degeneration

The National Eye Institute on Thursday said it will finance a two-year study comparing the effectiveness of Genentech's eye treatment Lucentis and cancer drug Avastin for treating wet age-related macular degeneration, the New York Times reports.

8 Oct 2006

FDA more cautious in approving new drugs after Vioxx

Many pharmaceutical companies and industry observers say that FDA is "quietly becoming more assertive about keeping new drugs off the market or refusing to approve new uses for existing medications" in response to criticism since the 2004 Vioxx recall, the New York Times reports.

3 Oct 2006

Curcumin useful in the fight against colorectal cancer

Looking for a cancer cure? Try the spice rack. In the last few years, that tactic has proved productive for researchers investigating turmeric, a curry spice used for centuries in Indian traditional medicine.

19 Sep 2006

Quality indicators for gastrointestinal endoscopic procedures

Defining measurements and identifying quality standards in the delivery of colonoscopic care is a major priority for the nation's leading gastrointestinal endoscopic healthcare association.

13 Sep 2006

Genetic code for breast and colon cancers

Johns Hopkins Kimmel Cancer Center scientists have completed the first draft of the genetic code for breast and colon cancers.

7 Sep 2006

VIOXX reduces risk of colorectal polyps

A researcher from Dartmouth reports the results of a clinical trial that shows that the cyclooxygenase-2 (COX-2) inhibitor rofecoxib (VIOXX.) reduces the risk of colorectal adenomas, or polyps.

30 Aug 2006

Celebrex shown to reduce incidence of potentially pre-malignant colorectal polyps

An international team of scientists reports that a single 400-milligram daily dose of celecoxib, commonly called Celebrex. and manufactured by Pfizer, significantly reduced recurrence of adenomas, or pre-malignant colon tumors - within three years of previous adenoma removal.

30 Aug 2006

Study shows diabetes link to colon cancer - smokers with type-2 diabetes face the greatest risk

A recent, clinically-confirmed study has shown that persons suffering from type-2 diabetes have an increased risk of developing colorectal cancer (CRC) when compared to the general public.

24 Aug 2006

Seven quality guidelines for breast, colorectal cancer care

The American Society of Clinical Oncology and the National Comprehensive Cancer Network on Tuesday released seven quality guidelines for breast and colorectal cancer care, CQ Today reports.

20 Aug 2006

Oxy-Q may help prevent colon cancer

A pilot clinical trial demonstrates that Oxy-Q, a proprietary pill by Farr Laboratories, LLC that combines the active components of turmeric and onions, reduces both the size and number of precancerous colon polyps.

8 Aug 2006

Probiotic drinks - not all brands live up to claims

According to experts as many as half of all probiotic health drinks do not contain the healthy bacteria they claim on the label.

8 Aug 2006

Researchers identify how molecules of microRNA are responsible for the growth of blood vessels in a model for human colon cancer

The process, called angiogenesis, results in ability of ravenous cancer cells to recruit blood vessels and receive a steady supply of nutrients and oxygen.

4 Aug 2006